A Feasibility Study of a Health Coaching Programme for Middle-aged Adults With Cardiometabolic Risk

The Chinese University of Hong Kong

Status

Completed

Conditions

Health Coaching

Middle-aged Adults

Primary Prevention

Cardiometabolic Disease

Treatments

Behavioral: Health coaching

Study type

Interventional

Funder types

Other

Identifiers

NCT05444140

Health coaching midlife pilot

Details and patient eligibility

About

Cardiometabolic disease has been an increasing trend globally and remains the major cause of morbidity and mortality. Health coaching, a process of goal-oriented and client-centered partnership that is health-focus and through client enlightenment and empowerment, are generally effective for chronic disease management and prevention of complication. However, there is inconclusive result on the effects of health coaching in the primary prevention of cardiometabolic diseases. Therefore, this study aimed to assess the feasibility and acceptability of a theory-guided health coaching programme for middle-aged adults with cardiometabolic risk.

Full description

A single group pretest-posttest feasibility study was conducted. The health coaching programme included four monthly health coaching sessions for three months. Feasibility of the study was measured by eligibility rate, enrollment rate, adherence rate, and attrition rate. Intervention acceptability was measured by satisfactory survey after completion of health coaching intervention. Feasibility of outcome measures was measured by the completion of outcome measures assessment at baseline and 6 months after enrollment.

Enrollment

30 patients

Sex

All

Ages

40 to 64 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

aged 40-64 years;
have a non-laboratory INTERHEART risk score (IHRS) of 16 or higher;
can communicate in Cantonese;
able to give informed consent.

Exclusion criteria

previous diagnosis of transient ischemic attack, stroke, myocardial infarction, atrial fibrillation, coronary heart disease, heart failure, dementia, chronic renal failure and diabetes;
currently on medication to control hyperlipidemia, diabetes or hypertension;
with eye or retinal disease;
diagnosis of terminal disease with an expected life expectancy less than 12 months;
currently participating in any other clinical trial;
currently participating in any other structured lifestyle-based or exercise-based programme.